Synthesis of 15-cis-(4-n-Propylcyclohexyl)-16,17,18,19,20-pentanor-9-deoxy-6,9α-nitriloprostaglandin F_1 Methyl Ester (OP-2507), a Novel Anti-cerebral Ischemic Agent
スポンサーリンク
概要
- 論文の詳細を見る
Synthesized was 15-cis-(4-n-propylcyclohexyl)-16,17,18,19,20-pentanor-9-deoxy-6,9α-nitrilo-prostaglandin F_1 methyl ester (OP-2507), a novel, promising anti-cerebral ischemic agent. A key intermediate, methyl cis-4-n-propylcyclohexanecarboxylate, was prepared stereoselectively by the hydrogenation of methyl 4-n-propylbenzoate with commercially available dimer of chloro(1,5-cyclooctadiene)rhodium as a catalyst. Stereoselective reduction of C_<15>-ketone to C_<15α>-alcohol was achieved with diisobutylaluminum 2,6-di-tert-butyl-4-methylphenoxide.
- 社団法人日本薬学会の論文
- 1988-03-25
著者
-
宮田 康行
Minase Research Institute Ono Pharmaceutical Co. Ltd.
-
井口 貞彦
Minase Research Institute, Ono Pharmaceutical Co., Ltd.,
-
奥山 繁広
Minase Research Institute, Ono Pharmaceutical Co., Ltd.,
-
三宅 八二六
Minase Research Institute, Ono Pharmaceutical Co., Ltd.,
-
桶川 忠夫
Minase Research Institute, Ono Pharmaceutical Co., Ltd.,
-
井口 貞彦
Minase Research Institute Ono Pharmaceutical Co. Ltd.
-
奥山 繁広
Minase Research Institute Ono Pharmaceutical Co. Ltd.
-
桶川 忠夫
Central Research Institute Ono Pharmaceutical Co. Ltd.
-
桶川 忠夫
Minase Research Institute Ono Pharmaceutical Co. Ltd.
-
三宅 八二六
Minase Research Institute Ono Pharmaceutical Co. Ltd.
関連論文
- Synthesis of 15-cis-(4-n-Propylcyclohexyl)-16,17,18,19,20-pentanor-9-deoxy-6,9α-nitriloprostaglandin F_1 Methyl Ester (OP-2507), a Novel Anti-cerebral Ischemic Agent
- Potent orally Active Inhibitors of Angiotensin-Converting Enzyme (ACE)
- Development of a Highly Cardioselective Ultra Short-Acting β-Blocker, ONO-1101
- Synthesis of Thromboxane B_3 and Its Direct Separation from Thromboxane B_2 by Reversed-Phase High Performance Liquid Chromatography
- (Ethyl p-(6-guanidinohexanoyloxy)benzoate)methanesulfonate(FOY)の一般薬理作用